Di-isodecyl Phthalate (DIDP); Draft Scope of the Risk Evaluation to be Conducted Under the Toxic Substances Control Act (TSCA); Notice of Availability and Request for Comments, 76077-76078 [2020-26203]
Download as PDF
Federal Register / Vol. 85, No. 229 / Friday, November 27, 2020 / Notices
Dated: November 19, 2020.
David Gray,
Acting Regional Administrator, Region 6.
ENVIRONMENTAL PROTECTION
AGENCY
[EPA–HQ–OPPT–2018–0435; FRL–10017–
14]
[FR Doc. 2020–26038 Filed 11–25–20; 8:45 am]
BILLING CODE 6560–50–P
Di-isodecyl Phthalate (DIDP); Draft
Scope of the Risk Evaluation to be
Conducted Under the Toxic
Substances Control Act (TSCA); Notice
of Availability and Request for
Comments
ENVIRONMENTAL PROTECTION
AGENCY
[ER–FRL–9054–1]
Environmental Protection
Agency (EPA).
ACTION: Notice.
AGENCY:
Environmental Impact Statements;
Notice of Availability
Responsible Agency: Office of Federal
Activities, General Information 202–
564–5632 or https://www.epa.gov/nepa.
Weekly receipt of Environmental Impact
Statements (EIS)
Filed November 16, 2020 10 a.m. EST
Through November 20, 2020 10 a.m.
EST
Pursuant to 40 CFR 1506.9.
Notice: Section 309(a) of the Clean Air
Act requires that EPA make public its
comments on EISs issued by other
Federal agencies. EPA’s comment letters
on EISs are available at: https://
cdxnodengn.epa.gov/cdx-enepa-public/
action/eis/search.
jbell on DSKJLSW7X2PROD with NOTICES
EIS No. 20200238, Draft, USFS, OR,
Stella Restoration Project, Comment
Period Ends: 01/12/2021, Contact:
Elizabeth Bly 541–560–3465.
EIS No. 20200239, Draft, USCG, TX,
Texas Gulflink Deepwater Port
License Application, Comment Period
Ends: 01/11/2021, Contact: Brad
McKitrick 202–372–1443.
EIS No. 20200240, Final, USFWS, REG,
Regulations Governing Take of
Migratory Birds, Review Period Ends:
12/28/2020, Contact: Lesley Kordella
703–963–1729.
EIS No. 20200241, Final, BLM, PRO,
Final Programmatic EIS for Fuels
Reduction and Rangeland Restoration
in the Great Basin, Review Period
Ends: 12/28/2020, Contact: Shannon
Bassista 208–373–3845.
EIS No. 20200242, Draft, USACE, VA,
Surry To Skiffes Creek To Whealton
Transmission Project, Comment
Period Ends: 01/11/2021, Contact:
Randy Steffey 757–201–7579.
Dated: November 20, 2020.
Cindy S. Barger,
Director, NEPA Compliance Division, Office
of Federal Activities.
[FR Doc. 2020–26179 Filed 11–25–20; 8:45 am]
BILLING CODE 6560–50–P
VerDate Sep<11>2014
19:29 Nov 25, 2020
Jkt 253001
The Environmental Protection
Agency (EPA) is announcing the
availability of and soliciting public
comment on the draft scope document
for the risk evaluation to be conducted
for di-isodecyl phthalate (DIDP) (1,2benzenedicarboxylic acid, 1,2diisodecyl ester and 1,2benzenedicarboxylic acid, di-C9-11branched alkyl esters, C10-rich;
Chemical Abstracts Service Registry
Number (CASRN) 26761–40–0 and
CASRN 68515–49–1), a category of
chemical substances for which EPA
received a manufacturer request for risk
evaluation. The draft scope document
for this category of chemical substances
includes the conditions of use, hazards,
exposures, and the potentially exposed
or susceptible subpopulations EPA
plans to consider in conducting the risk
evaluation for this category of chemical
substances. EPA is also asking the
public to provide additional data or
information that could be useful to the
Agency in finalizing the scope of the
risk evaluation.
DATES: Comments must be received on
or before January 11, 2021.
ADDRESSES: Submit your comments,
identified by docket identification (ID)
number EPA–HQ–OPPT–2018–0435,
through the Federal eRulemaking Portal
at https://www.regulations.gov. Follow
the online instructions for submitting
comments. Do not submit electronically
any information you consider to be
Confidential Business Information (CBI)
or other information whose disclosure is
restricted by statute. To make special
arrangements for hand delivery or
delivery of boxed information, please
follow the instructions at https://
www.epa.gov/dockets/contacts.html.
Due to the public health concerns
related to COVID–19, the EPA Docket
Center (EPA/DC) and Reading Room is
closed to visitors with limited
exceptions. The staff continues to
provide remote customer service via
email, phone, and webform. For the
latest status information on EPA/DC
SUMMARY:
PO 00000
Frm 00074
Fmt 4703
Sfmt 4703
76077
services and docket access, visit https://
www.epa.gov/dockets.
FOR FURTHER INFORMATION CONTACT:
For technical information contact:
Collin Beachum, Existing Chemical Risk
Assessment Division (Mailcode E205–
02), Office of Pollution Prevention and
Toxics, Environmental Protection
Agency, 109 T.W. Alexander Drive,
RTP, NC 27711; telephone number:
(919) 541–7554; email address:
beachum.collin@epa.gov.
For general information contact: The
TSCA-Hotline, ABVI-Goodwill, 422
South Clinton Ave., Rochester, NY
14620; telephone number: (202) 554–
1404; email address: TSCA-Hotline@
epa.gov.
SUPPLEMENTARY INFORMATION:
I. General Information
A. Does this action apply to me?
This action is directed to the public
in general and may be of interest to
entities that manufacture (including
import) a chemical substance regulated
under TSCA (e.g., entities identified
under North American Industrial
Classification System (NAICS) codes
325 and 324110). The action may also
be of interest to chemical processors,
distributors in commerce, and users;
non-governmental organizations in the
environmental and public health
sectors; state and local government
agencies; and members of the public.
Since other entities may also be
interested, the Agency has not
attempted to describe all the specific
entities and corresponding NAICS codes
for entities that may be interested in or
affected by this action.
B. What is the Agency’s authority for
taking this action?
The draft scope document is issued
pursuant to TSCA section 6(b) and
EPA’s implementing regulations at 40
CFR 702.41(c)(7).
C. What action is the Agency taking?
EPA is publishing the draft scope of
the risk evaluation for DIDP under
TSCA. Through the risk evaluation
process, EPA will determine whether
the category of chemical substances
presents an unreasonable risk of injury
to health or the environment under the
conditions of use, as determined by the
Administrator, in accordance with
TSCA section 6(b)(4).
II. Background
TSCA allows chemical manufacturers
to request an EPA-conducted risk
evaluation of a chemical under 40 CFR
702.37. On May 24, 2019, EPA received
a manufacturer request for a risk
E:\FR\FM\27NON1.SGM
27NON1
76078
Federal Register / Vol. 85, No. 229 / Friday, November 27, 2020 / Notices
jbell on DSKJLSW7X2PROD with NOTICES
evaluation of DIDP. On December 20,
2019, the Agency granted the request,
and subsequently initiated the scoping
process for a risk evaluation for this
category of chemical substances. The
purpose of a risk evaluation is to
determine whether a chemical
substance, or group of chemical
substances, presents an unreasonable
risk to health or the environment, under
the conditions of use, including an
unreasonable risk to a relevant
potentially exposed or susceptible
subpopulation (15 U.S.C. 2605(b)(4)(A)).
As part of this process, EPA must
evaluate both hazards and exposures for
the conditions of use; describe whether
aggregate or sentinel exposures were
considered and the basis for
consideration; not consider costs or
other nonrisk factors; take into account
where relevant, likely duration,
intensity, frequency, and number of
exposures and describe the weight of
the scientific evidence for hazards and
exposures (15 U.S.C. 2605(b)(4)(F)). This
process will culminate in a
determination of whether or not the
category of chemical substances
presents an unreasonable risk of injury
to health or the environment under the
conditions of use (15 U.S.C.
2605(b)(4)(A); 40 CFR 702.47).
III. Draft Scope of the Risk Evaluation
for Di-isodecyl phthalate (DIDP)
The category of chemical substances
for which EPA is publishing the draft
scope of the risk evaluation includes the
following chemical substances: 1,2benzenedicarboxylic acid, 1,2diisodecyl ester (CASRN 26761–40–0)
and 1,2-benzenedicarboxylic acid, diC9-11-branched alkyl esters, C10-rich;
(CASRN 68515–49–1). The draft scope
of the risk evaluation for this category
of chemical substances includes the
conditions of use, hazards, exposures,
and the potentially exposed or
susceptible subpopulations EPA plans
to consider in the risk evaluation (15
U.S.C. 2605(b)(4)(D)).
Development of the scope is the first
step of a risk evaluation. The draft scope
of the risk evaluation will include the
following components (40 CFR
702.41(c)):
• The conditions of use, as
determined by the Administrator, that
EPA plans to consider in the risk
evaluation.
• The potentially exposed
populations that EPA plans to evaluate;
the ecological receptors that EPA plans
to evaluate; and the hazards to health
and the environment that EPA plans to
evaluate.
• A description of the reasonably
available information and the science
VerDate Sep<11>2014
19:29 Nov 25, 2020
Jkt 253001
approaches that the Agency plans to
use.
• A conceptual model that will
describe the actual or predicted
relationships between the chemical
substance, the conditions of use within
the scope of the evaluation and the
receptors, either human or
environmental, with consideration of
the life cycle of the chemical
substance—from manufacturing,
processing, distribution in commerce,
use, to release or disposal—and
identification of human and ecological
health hazards EPA plans to evaluate for
the exposure scenarios EPA plans to
evaluate.
• An analysis plan, which will
identify the approaches and methods
EPA plans to use to assess exposure,
hazards, and risk, including associated
uncertainty and variability, as well as a
strategy for using reasonably available
information and best available science
approaches.
• A plan for peer review.
EPA encourages commenters to
provide information they believe might
be missing or may further inform the
risk evaluation. EPA will publish a
notice in the Federal Register
announcing the availability of the final
scope within three months of publishing
the draft scope.
IV. References
The following is a listing of the
documents that are specifically
referenced in this Federal Register
notice. The docket for this action
includes these documents and other
information considered by EPA,
including documents that are referenced
within the documents that are included
in the docket. For assistance in locating
these referenced documents, please
consult the technical person listed
under FOR FURTHER INFORMATION
CONTACT.
1. EPA. Di-isodecyl Phthalate (DIDP)
(1,2-Benzene-dicarboxylic acid, 1,2diisodecyl ester); Manufacturer Request
for Risk Evaluation Under the Toxic
Substances Control Act (TSCA); Notice
of Availability and Request for
Comments. Federal Register. (84 FR
42914, August 30, 2019) (FRL–9998–26).
(Authority: 15 U.S.C. 2601 et seq.)
Andrew Wheeler,
Administrator.
[FR Doc. 2020–26203 Filed 11–25–20; 8:45 am]
BILLING CODE 6560–50–P
PO 00000
Frm 00075
Fmt 4703
Sfmt 4703
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Medicare & Medicaid
Services
[Document Identifier: CMS–10292 and CMS–
R–65]
Agency Information Collection
Activities: Proposed Collection;
Comment Request
Centers for Medicare &
Medicaid Services, Health and Human
Services (HHS).
ACTION: Notice.
AGENCY:
The Centers for Medicare &
Medicaid Services (CMS) is announcing
an opportunity for the public to
comment on CMS’ intention to collect
information from the public. Under the
Paperwork Reduction Act of 1995 (the
PRA), federal agencies are required to
publish notice in the Federal Register
concerning each proposed collection of
information (including each proposed
extension or reinstatement of an existing
collection of information) and to allow
60 days for public comment on the
proposed action. Interested persons are
invited to send comments regarding our
burden estimates or any other aspect of
this collection of information, including
the necessity and utility of the proposed
information collection for the proper
performance of the agency’s functions,
the accuracy of the estimated burden,
ways to enhance the quality, utility, and
clarity of the information to be
collected, and the use of automated
collection techniques or other forms of
information technology to minimize the
information collection burden.
DATES: Comments must be received by
January 26, 2021.
ADDRESSES: When commenting, please
reference the document identifier or
OMB control number. To be assured
consideration, comments and
recommendations must be submitted in
any one of the following ways:
1. Electronically. You may send your
comments electronically to https://
www.regulations.gov. Follow the
instructions for ‘‘Comment or
Submission’’ or ‘‘More Search Options’’
to find the information collection
document(s) that are accepting
comments.
2. By regular mail. You may mail
written comments to the following
address:
CMS, Office of Strategic Operations
and Regulatory Affairs, Division of
Regulations Development, Attention:
Document Identifier/OMB Control
Number lllllll, Room C4–26–
SUMMARY:
E:\FR\FM\27NON1.SGM
27NON1
Agencies
[Federal Register Volume 85, Number 229 (Friday, November 27, 2020)]
[Notices]
[Pages 76077-76078]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-26203]
-----------------------------------------------------------------------
ENVIRONMENTAL PROTECTION AGENCY
[EPA-HQ-OPPT-2018-0435; FRL-10017-14]
Di-isodecyl Phthalate (DIDP); Draft Scope of the Risk Evaluation
to be Conducted Under the Toxic Substances Control Act (TSCA); Notice
of Availability and Request for Comments
AGENCY: Environmental Protection Agency (EPA).
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The Environmental Protection Agency (EPA) is announcing the
availability of and soliciting public comment on the draft scope
document for the risk evaluation to be conducted for di-isodecyl
phthalate (DIDP) (1,2-benzenedicarboxylic acid, 1,2-diisodecyl ester
and 1,2-benzenedicarboxylic acid, di-C9-11-branched alkyl esters, C10-
rich; Chemical Abstracts Service Registry Number (CASRN) 26761-40-0 and
CASRN 68515-49-1), a category of chemical substances for which EPA
received a manufacturer request for risk evaluation. The draft scope
document for this category of chemical substances includes the
conditions of use, hazards, exposures, and the potentially exposed or
susceptible subpopulations EPA plans to consider in conducting the risk
evaluation for this category of chemical substances. EPA is also asking
the public to provide additional data or information that could be
useful to the Agency in finalizing the scope of the risk evaluation.
DATES: Comments must be received on or before January 11, 2021.
ADDRESSES: Submit your comments, identified by docket identification
(ID) number EPA-HQ-OPPT-2018-0435, through the Federal eRulemaking
Portal at https://www.regulations.gov. Follow the online instructions
for submitting comments. Do not submit electronically any information
you consider to be Confidential Business Information (CBI) or other
information whose disclosure is restricted by statute. To make special
arrangements for hand delivery or delivery of boxed information, please
follow the instructions at https://www.epa.gov/dockets/contacts.html.
Due to the public health concerns related to COVID-19, the EPA
Docket Center (EPA/DC) and Reading Room is closed to visitors with
limited exceptions. The staff continues to provide remote customer
service via email, phone, and webform. For the latest status
information on EPA/DC services and docket access, visit https://www.epa.gov/dockets.
FOR FURTHER INFORMATION CONTACT:
For technical information contact: Collin Beachum, Existing
Chemical Risk Assessment Division (Mailcode E205-02), Office of
Pollution Prevention and Toxics, Environmental Protection Agency, 109
T.W. Alexander Drive, RTP, NC 27711; telephone number: (919) 541-7554;
email address: [email protected].
For general information contact: The TSCA-Hotline, ABVI-Goodwill,
422 South Clinton Ave., Rochester, NY 14620; telephone number: (202)
554-1404; email address: [email protected].
SUPPLEMENTARY INFORMATION:
I. General Information
A. Does this action apply to me?
This action is directed to the public in general and may be of
interest to entities that manufacture (including import) a chemical
substance regulated under TSCA (e.g., entities identified under North
American Industrial Classification System (NAICS) codes 325 and
324110). The action may also be of interest to chemical processors,
distributors in commerce, and users; non-governmental organizations in
the environmental and public health sectors; state and local government
agencies; and members of the public. Since other entities may also be
interested, the Agency has not attempted to describe all the specific
entities and corresponding NAICS codes for entities that may be
interested in or affected by this action.
B. What is the Agency's authority for taking this action?
The draft scope document is issued pursuant to TSCA section 6(b)
and EPA's implementing regulations at 40 CFR 702.41(c)(7).
C. What action is the Agency taking?
EPA is publishing the draft scope of the risk evaluation for DIDP
under TSCA. Through the risk evaluation process, EPA will determine
whether the category of chemical substances presents an unreasonable
risk of injury to health or the environment under the conditions of
use, as determined by the Administrator, in accordance with TSCA
section 6(b)(4).
II. Background
TSCA allows chemical manufacturers to request an EPA-conducted risk
evaluation of a chemical under 40 CFR 702.37. On May 24, 2019, EPA
received a manufacturer request for a risk
[[Page 76078]]
evaluation of DIDP. On December 20, 2019, the Agency granted the
request, and subsequently initiated the scoping process for a risk
evaluation for this category of chemical substances. The purpose of a
risk evaluation is to determine whether a chemical substance, or group
of chemical substances, presents an unreasonable risk to health or the
environment, under the conditions of use, including an unreasonable
risk to a relevant potentially exposed or susceptible subpopulation (15
U.S.C. 2605(b)(4)(A)). As part of this process, EPA must evaluate both
hazards and exposures for the conditions of use; describe whether
aggregate or sentinel exposures were considered and the basis for
consideration; not consider costs or other nonrisk factors; take into
account where relevant, likely duration, intensity, frequency, and
number of exposures and describe the weight of the scientific evidence
for hazards and exposures (15 U.S.C. 2605(b)(4)(F)). This process will
culminate in a determination of whether or not the category of chemical
substances presents an unreasonable risk of injury to health or the
environment under the conditions of use (15 U.S.C. 2605(b)(4)(A); 40
CFR 702.47).
III. Draft Scope of the Risk Evaluation for Di-isodecyl phthalate
(DIDP)
The category of chemical substances for which EPA is publishing the
draft scope of the risk evaluation includes the following chemical
substances: 1,2-benzenedicarboxylic acid, 1,2-diisodecyl ester (CASRN
26761-40-0) and 1,2-benzenedicarboxylic acid, di-C9-11-branched alkyl
esters, C10-rich; (CASRN 68515-49-1). The draft scope of the risk
evaluation for this category of chemical substances includes the
conditions of use, hazards, exposures, and the potentially exposed or
susceptible subpopulations EPA plans to consider in the risk evaluation
(15 U.S.C. 2605(b)(4)(D)).
Development of the scope is the first step of a risk evaluation.
The draft scope of the risk evaluation will include the following
components (40 CFR 702.41(c)):
The conditions of use, as determined by the Administrator,
that EPA plans to consider in the risk evaluation.
The potentially exposed populations that EPA plans to
evaluate; the ecological receptors that EPA plans to evaluate; and the
hazards to health and the environment that EPA plans to evaluate.
A description of the reasonably available information and
the science approaches that the Agency plans to use.
A conceptual model that will describe the actual or
predicted relationships between the chemical substance, the conditions
of use within the scope of the evaluation and the receptors, either
human or environmental, with consideration of the life cycle of the
chemical substance--from manufacturing, processing, distribution in
commerce, use, to release or disposal--and identification of human and
ecological health hazards EPA plans to evaluate for the exposure
scenarios EPA plans to evaluate.
An analysis plan, which will identify the approaches and
methods EPA plans to use to assess exposure, hazards, and risk,
including associated uncertainty and variability, as well as a strategy
for using reasonably available information and best available science
approaches.
A plan for peer review.
EPA encourages commenters to provide information they believe might
be missing or may further inform the risk evaluation. EPA will publish
a notice in the Federal Register announcing the availability of the
final scope within three months of publishing the draft scope.
IV. References
The following is a listing of the documents that are specifically
referenced in this Federal Register notice. The docket for this action
includes these documents and other information considered by EPA,
including documents that are referenced within the documents that are
included in the docket. For assistance in locating these referenced
documents, please consult the technical person listed under FOR FURTHER
INFORMATION CONTACT.
1. EPA. Di-isodecyl Phthalate (DIDP) (1,2-Benzene-dicarboxylic
acid, 1,2- diisodecyl ester); Manufacturer Request for Risk Evaluation
Under the Toxic Substances Control Act (TSCA); Notice of Availability
and Request for Comments. Federal Register. (84 FR 42914, August 30,
2019) (FRL-9998-26).
(Authority: 15 U.S.C. 2601 et seq.)
Andrew Wheeler,
Administrator.
[FR Doc. 2020-26203 Filed 11-25-20; 8:45 am]
BILLING CODE 6560-50-P